Research to reality: applying REGENETEN RCT findings to your practice
In the upcoming live session on 25 April 2024, 5pm EST, the surgeon panel will outline how randomized controlled trial data strengthens their goal to improve patient outcomes with bioinductive augmentation.
Register here:
Dr Jacob Calcei, Dr Xavier Duralde, Dr Michael O'Brien and Dr Miguel Ruiz Ibán are ready to share their stories and insights on:
- How evidence points to a 3x reduction in re-tears and better tendon integrity
- How to select the right patients
- How initial skepticism can become a strong belief in REGENETEN’s transformative impact